Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths ...

The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus ...

Abbott recalls glucose sensors linked to 7 deaths and 860 serious injuries; FDA urges discontinuation of specific FreeStyle Libre 3 models.

Abbott Laboratories is cited for four key alleged violations related to the production of its Freestyle Libre continuous glucose monitoring devices.

- Findings from the RELIEF study in France showed for the first time, in the largest retrospective analysis of its kind of nearly 75,000 people living with diabetes, use of the FreeStyle Libre system ...

The U.S. Food and Drug Administration (FDA) on Wednesday categorized a product recall initiated by Abbott Laboratories (ABT) affecting certain lots of its glucose monitor sensors as the most serious ...

At least seven fires and one injury that were related to some FreeStyle Libre glucose monitor products have led the US Food and Drug Administration to issue a Class I recall, the agency's strongest, ...

First and only continuous glucose monitoring system to be nationally reimbursed in France for people who use once-daily (basal) insulin 1 Expanded reimbursement facilitates wider access to continuous ...

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater ...

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes. The Food and Drug Administration (FDA) has ...

ABBOTT PARK, Ill., June 22, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the French health authority has approved the expansion of reimbursement coverage for its FreeStyle Libre 2 ...